首页 > 最新文献

Surgery for Obesity and Related Diseases最新文献

英文 中文
Predictors and weight impact of postbariatric hypoglycemia after Roux-en-Y gastric bypass surgery: a prospective observational cohort study Roux-en-Y 胃旁路手术后低血糖症的预测因素和对体重的影响:前瞻性观察队列研究
IF 3.5 3区 医学 Q1 SURGERY Pub Date : 2024-12-01 DOI: 10.1016/j.soard.2024.06.006
Anouk Lüscher , Nathalie Vionnet M.D., Ph.D. , Jérôme Pasquier M.D., Ph.D. , Dionysios Chartoumpekis M.D., Ph.D. , Styliani Mantziari M.D., M.Sc. , Anne Wojtsusizyn M.D. , Lucie Favre M.D.

Background

Postbariatric hypoglycemia (PBH) is a challenging condition affecting quality of life of patients after bariatric surgery. However, its incidence and predictive factors remain debated.

Objectives

To determine the incidence of PBH, identify predictors of PBH and assess its association with weight trajectory after bariatric surgery.

Setting

University Hospital.

Methods

Prospective observational cohort study including 222 nondiabetic patients who underwent Roux-en-Y gastric bypass between 2014 and 2021, had an oral glucose tolerance test (OGTT) and/or A1C (glycated hemoglobin) measurement prior to surgery and were followed for at least 12 months. Diagnosis of PBH was made when symptoms of hypoglycemia were accompanied by a postprandial plasma glucose level < 3.9 mmol/l or a glycemia < 3.9 mmol/l during continuous glucose monitoring, with resolution of symptomatology after carbohydrate consumption. Univariable and multivariable logistic regression analyses were performed to identify factors associated with PBH.

Results

Out of 222 patients, 71 (32%) were diagnosed with PBH. The highest incidence rate was observed at 2 years postbariatric surgery with a cumulative incidence of 26.5%. Predictive factors for higher risk of PBH were younger age at surgery (OR = .97; 95% CI: .94–.99; P = .049) and early dumping syndrome (OR = 3.05; 95% CI: 1.62–6.04; P = .0008). In multivariable logistic regression, higher glycemia at 2 hours during preoperative OGTT was associated with lower risk of PBH (OR = .8; 95% CI: .63–.98; P = .04). PBH was not associated with weight trajectory after surgery in our cohort.

Conclusions

Younger age at time of surgery and lower blood glucose at 120 minute during preoperative OGTT are risk factors for PBH. Early dumping syndrome is significantly associated with PBH and could be used as a red flag to help identify patients at risk of PBH.
背景:减肥后低血糖(PBH)是影响减肥手术后患者生活质量的一种具有挑战性的疾病。然而,其发病率和预测因素仍存在争议。目的确定PBH的发病率,确定PBH的预测因素,并评估其与减肥手术后体重轨迹的关系。SettingUniversity医院。方法前瞻性观察队列研究包括222名2014 - 2021年间接受Roux-en-Y胃旁路治疗的非糖尿病患者,术前进行口服葡萄糖耐量试验(OGTT)和/或糖化血红蛋白(A1C)测量,并随访至少12个月。当低血糖症状伴有餐后血糖水平时,可诊断为PBH;3.9 mmol/l或升糖;持续血糖监测时为3.9 mmol/l,消耗碳水化合物后症状缓解。进行单变量和多变量logistic回归分析以确定与PBH相关的因素。结果222例患者中,71例(32%)诊断为PBH。在减肥手术后2年的发病率最高,累计发病率为26.5%。PBH高风险的预测因素为手术年龄较小(OR = 0.97;95% ci: 0.94 - 0.99;P = 0.049)和早期倾倒综合征(OR = 3.05;95% ci: 1.62-6.04;P = .0008)。在多变量logistic回归中,OGTT术前2小时血糖升高与PBH风险降低相关(OR = .8;95% ci: 0.63 - 0.98;P = .04)。在我们的队列中,PBH与术后体重轨迹无关。结论手术年龄小、OGTT术前120分钟血糖较低是发生PBH的危险因素。早期倾倒综合征与PBH显著相关,可以作为一个危险信号来帮助识别有PBH风险的患者。
{"title":"Predictors and weight impact of postbariatric hypoglycemia after Roux-en-Y gastric bypass surgery: a prospective observational cohort study","authors":"Anouk Lüscher ,&nbsp;Nathalie Vionnet M.D., Ph.D. ,&nbsp;Jérôme Pasquier M.D., Ph.D. ,&nbsp;Dionysios Chartoumpekis M.D., Ph.D. ,&nbsp;Styliani Mantziari M.D., M.Sc. ,&nbsp;Anne Wojtsusizyn M.D. ,&nbsp;Lucie Favre M.D.","doi":"10.1016/j.soard.2024.06.006","DOIUrl":"10.1016/j.soard.2024.06.006","url":null,"abstract":"<div><h3>Background</h3><div>Postbariatric hypoglycemia (PBH) is a challenging condition affecting quality of life of patients after bariatric surgery. However, its incidence and predictive factors remain debated.</div></div><div><h3>Objectives</h3><div>To determine the incidence of PBH, identify predictors of PBH and assess its association with weight trajectory after bariatric surgery.</div></div><div><h3>Setting</h3><div>University Hospital.</div></div><div><h3>Methods</h3><div>Prospective observational cohort study including 222 nondiabetic patients who underwent Roux-en-Y gastric bypass between 2014 and 2021, had an oral glucose tolerance test (OGTT) and/or A1C (glycated hemoglobin) measurement prior to surgery and were followed for at least 12 months. Diagnosis of PBH was made when symptoms of hypoglycemia were accompanied by a postprandial plasma glucose level &lt; 3.9 mmol/l or a glycemia &lt; 3.9 mmol/l during continuous glucose monitoring, with resolution of symptomatology after carbohydrate consumption. Univariable and multivariable logistic regression analyses were performed to identify factors associated with PBH.</div></div><div><h3>Results</h3><div>Out of 222 patients, 71 (32%) were diagnosed with PBH. The highest incidence rate was observed at 2 years postbariatric surgery with a cumulative incidence of 26.5%. Predictive factors for higher risk of PBH were younger age at surgery (OR = .97; 95% CI: .94–.99; <em>P</em> = .049) and early dumping syndrome (OR = 3.05; 95% CI: 1.62–6.04; <em>P</em> = .0008). In multivariable logistic regression, higher glycemia at 2 hours during preoperative OGTT was associated with lower risk of PBH (OR = .8; 95% CI: .63–.98; <em>P</em> = .04). PBH was not associated with weight trajectory after surgery in our cohort.</div></div><div><h3>Conclusions</h3><div>Younger age at time of surgery and lower blood glucose at 120 minute during preoperative OGTT are risk factors for PBH. Early dumping syndrome is significantly associated with PBH and could be used as a red flag to help identify patients at risk of PBH.</div></div>","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"20 12","pages":"Pages 1187-1195"},"PeriodicalIF":3.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141704174","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Observations of Ramadan fasting in the initial year after bariatric surgery "减肥手术后第一年的斋月禁食观察"
IF 3.5 3区 医学 Q1 SURGERY Pub Date : 2024-12-01 DOI: 10.1016/j.soard.2024.07.010
Ala Wafa M.D. , Jessica G. Cunningham M.D., Ph.D. , Ali Shagan M.D. , Suleiman Naji M.D. , Rawad Friwan M.D. , Salim Abunnaja M.D., F.A.C.S., F.A.S.M.B.S.

Background

Ramadan is considered to be the holiest month of the Islamic religion. Hundreds of millions of Muslims practice the commitments of Ramadan, which include the abstinence from eating and drinking during daylight hours. Although there are exemptions to fasting for medical reasons, there is very limited guidance in terms of the safety of fasting in the postoperative period after bariatric surgery.

Objectives

To assess outcomes and impact of fasting on patients who underwent bariatric surgery within the year leading up to Ramadan 2023.

Setting

Community hospital health system.

Methods

Retrospective review of medical records and direct patient contact for 376 study participants.

Results

Of the 376 participants who underwent bariatric surgery in the year before Ramadan, only 8 patients (2.1%) reported they did not intend to fast during Ramadan. Patients who ended up having to break fasting were closer to their surgery date, at 4.3 months from surgery, than patients who were able to fast for the entire month of Ramadan, who were 5.1 months out from surgery. There was no difference between the number of patients needing to break fasting on the basis of what type of bariatric surgery they had performed. The number of patients needing to go to the emergency department and receive intravenous fluids was small, at 11 patients (2.9%), and these patients were also closer to surgery than those not needing to go to the emergency department or receive intravenous fluids. Side effects experienced during Ramadan, including abdominal pain, nausea/vomiting, and hypoglycemia, were more common in patients that were closer to their surgery, notably within 4 months of their surgery date. Patients who lost weight during Ramadan were closer to their surgery date at 4.9 months from surgery compared with those who maintained or gained weight, who were 7.0 months out from surgery.

Conclusions

There are a limited number of studies examining the safety and patient outcomes in those who fast for religious purposes after bariatric surgery. In this study, 376 participants who were within 1 year of undergoing surgery were followed throughout the month of Ramadan. Patients closer to surgery were more likely to break fasting, present to the emergency department, and experience side effects. However, the overall rate of complications was low, suggesting that fasting in the setting of a religious tradition in the carefully chosen patient with counseling and supervision may be a safe option.
斋月被认为是伊斯兰教中最神圣的月份。数亿穆斯林践行斋月的承诺,其中包括白天不吃不喝。虽然出于医疗原因的禁食有豁免,但在减肥手术后禁食的安全性方面,指导非常有限。目的评估在2023年斋月前一年内接受减肥手术的患者禁食的结果和影响。社区医院卫生系统。方法回顾性分析376名研究参与者的医疗记录和患者的直接接触。结果在斋月前一年接受减肥手术的376名参与者中,只有8名患者(2.1%)报告他们不打算在斋月期间禁食。最终不得不打破禁食的患者比那些能够在整个斋月禁食的患者(手术后5.1个月)更接近手术日期(手术后4.3个月)。不同类型的减肥手术患者需要断食的数量没有差别。需要去急诊科接受静脉输液的患者数量较少,为11例(2.9%),这些患者也比不需要去急诊科或接受静脉输液的患者更接近手术。斋月期间出现的副作用,包括腹痛、恶心/呕吐和低血糖,在接近手术的患者中更为常见,尤其是在手术日期后4个月内。在斋月期间减肥的患者在手术后4.9个月更接近手术日期,而体重保持或增加的患者在手术后7.0个月更接近手术日期。结论:在减肥手术后为宗教目的禁食的患者的安全性和结果的研究数量有限。在这项研究中,376名接受手术一年内的参与者在整个斋月期间被跟踪。接近手术的患者更有可能打破禁食,出现在急诊科,并经历副作用。然而,并发症的总体发生率很低,这表明在宗教传统的背景下,在精心挑选的病人中进行禁食,并进行咨询和监督,可能是一个安全的选择。
{"title":"Observations of Ramadan fasting in the initial year after bariatric surgery","authors":"Ala Wafa M.D. ,&nbsp;Jessica G. Cunningham M.D., Ph.D. ,&nbsp;Ali Shagan M.D. ,&nbsp;Suleiman Naji M.D. ,&nbsp;Rawad Friwan M.D. ,&nbsp;Salim Abunnaja M.D., F.A.C.S., F.A.S.M.B.S.","doi":"10.1016/j.soard.2024.07.010","DOIUrl":"10.1016/j.soard.2024.07.010","url":null,"abstract":"<div><h3>Background</h3><div>Ramadan is considered to be the holiest month of the Islamic religion. Hundreds of millions of Muslims practice the commitments of Ramadan, which include the abstinence from eating and drinking during daylight hours. Although there are exemptions to fasting for medical reasons, there is very limited guidance in terms of the safety of fasting in the postoperative period after bariatric surgery.</div></div><div><h3>Objectives</h3><div>To assess outcomes and impact of fasting on patients who underwent bariatric surgery within the year leading up to Ramadan 2023.</div></div><div><h3>Setting</h3><div>Community hospital health system.</div></div><div><h3>Methods</h3><div>Retrospective review of medical records and direct patient contact for 376 study participants.</div></div><div><h3>Results</h3><div>Of the 376 participants who underwent bariatric surgery in the year before Ramadan, only 8 patients (2.1%) reported they did not intend to fast during Ramadan. Patients who ended up having to break fasting were closer to their surgery date, at 4.3 months from surgery, than patients who were able to fast for the entire month of Ramadan, who were 5.1 months out from surgery. There was no difference between the number of patients needing to break fasting on the basis of what type of bariatric surgery they had performed. The number of patients needing to go to the emergency department and receive intravenous fluids was small, at 11 patients (2.9%), and these patients were also closer to surgery than those not needing to go to the emergency department or receive intravenous fluids. Side effects experienced during Ramadan, including abdominal pain, nausea/vomiting, and hypoglycemia, were more common in patients that were closer to their surgery, notably within 4 months of their surgery date. Patients who lost weight during Ramadan were closer to their surgery date at 4.9 months from surgery compared with those who maintained or gained weight, who were 7.0 months out from surgery.</div></div><div><h3>Conclusions</h3><div>There are a limited number of studies examining the safety and patient outcomes in those who fast for religious purposes after bariatric surgery. In this study, 376 participants who were within 1 year of undergoing surgery were followed throughout the month of Ramadan. Patients closer to surgery were more likely to break fasting, present to the emergency department, and experience side effects. However, the overall rate of complications was low, suggesting that fasting in the setting of a religious tradition in the carefully chosen patient with counseling and supervision may be a safe option.</div></div>","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"20 12","pages":"Pages 1253-1259"},"PeriodicalIF":3.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141849266","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cancer incidence following bariatric surgery in renal transplant recipients: a retrospective multi-center analysis 肾移植受者减肥手术后的癌症发病率:一项回顾性多中心
IF 3.5 3区 医学 Q1 SURGERY Pub Date : 2024-12-01 DOI: 10.1016/j.soard.2024.06.010
Laxmi Dongur M.D. , Yara Samman B.S. , George Golovko Ph.D. , Kostiantyn Botnar Ph.D. , Michael L. Kueht M.D., F.A.C.S. , Jennifer Moffett M.D., F.A.C.S. , Sarah Samreen M.D., F.A.C.S.

Background

Obesity, a known independent risk factor for developing malignancy. Additionally, renal transplant recipients (RTR) confer a 2- to 4-fold increased risk of overall malignancies with an excess absolute risk of .7% per year. While transplant recipients are at risk for obesity and malignancy, the effect of bariatric surgery (BS) in the posttransplantation setting is not well known.

Objectives

Our study primarily evaluated the impact of BS on cancer incidence in RTR with severe obesity in the posttransplantation setting. Weight loss outcomes were analyzed secondarily.

Setting

University Hospital.

Methods

A retrospective study using TriNetX database was developed to analyze cancer outcomes in RTR with posttransplantation BS versus RTR without BS from 2000 to 2023. After the exclusion process and propensity matching, both cohorts consisted of 153 patients.

Results

RTR-BS had a significantly lower incidence of overall cancer and transplant-related cancers (P < .05). No significant difference was identified in cutaneous, gastrointestinal, and reproductive cancers. Percent Excess Weight Loss (%EWL) was significantly lower in RTR-only cohort (11.4%) versus RTR-BS cohort (57.8%) at 5 years. Sleeve gastrectomy (SG) patients (73.19%) had significantly higher %EWL than Roux en-Y gastric bypass (RYGB) patients (49.33%) at 3 years. No difference in cancer incidence was noted between SG and RYGB patients.

Conclusion

Postrenal transplantation BS had a diminishing effect on overall and transplant-related cancer incidence in RTR with severe obesity. Significant weight loss was also demonstrated with post-renal transplantation BS.
背景:肥胖是恶性肿瘤发生的独立危险因素。此外,肾移植受者(RTR)的总体恶性肿瘤风险增加2- 4倍,每年的绝对风险超过0.7%。虽然移植受者有肥胖和恶性肿瘤的风险,但减肥手术(BS)在移植后环境中的效果尚不清楚。目的:本研究主要评估BS对移植后重度肥胖RTR患者癌症发病率的影响。其次分析减肥结果。SettingUniversity医院。方法采用TriNetX数据库进行回顾性研究,分析2000年至2023年伴有移植后BS的RTR与不伴有BS的RTR的癌症结局。在排除过程和倾向匹配之后,两个队列包括153名患者。结果rtr - bs患者总体癌症和移植相关癌症的发生率显著降低(P <;. 05)。在皮肤癌、胃肠道癌和生殖癌中没有发现显著差异。5年时,仅rtr组的超重减重率(%EWL)显著低于RTR-BS组(57.8%)(11.4%)。袖胃切除术(SG)患者3年EWL(73.19%)明显高于Roux en-Y胃旁路(RYGB)患者(49.33%)。SG和RYGB患者的癌症发病率没有差异。结论肾移植后BS对重度肥胖RTR患者总体及移植相关癌症发病率的影响减弱。肾移植后BS患者体重明显减轻。
{"title":"Cancer incidence following bariatric surgery in renal transplant recipients: a retrospective multi-center analysis","authors":"Laxmi Dongur M.D. ,&nbsp;Yara Samman B.S. ,&nbsp;George Golovko Ph.D. ,&nbsp;Kostiantyn Botnar Ph.D. ,&nbsp;Michael L. Kueht M.D., F.A.C.S. ,&nbsp;Jennifer Moffett M.D., F.A.C.S. ,&nbsp;Sarah Samreen M.D., F.A.C.S.","doi":"10.1016/j.soard.2024.06.010","DOIUrl":"10.1016/j.soard.2024.06.010","url":null,"abstract":"<div><h3>Background</h3><div>Obesity, a known independent risk factor for developing malignancy. Additionally, renal transplant recipients (RTR) confer a 2- to 4-fold increased risk of overall malignancies with an excess absolute risk of .7% per year. While transplant recipients are at risk for obesity and malignancy, the effect of bariatric surgery (BS) in the posttransplantation setting is not well known.</div></div><div><h3>Objectives</h3><div>Our study primarily evaluated the impact of BS on cancer incidence in RTR with severe obesity in the posttransplantation setting. Weight loss outcomes were analyzed secondarily.</div></div><div><h3>Setting</h3><div>University Hospital.</div></div><div><h3>Methods</h3><div>A retrospective study using TriNetX database was developed to analyze cancer outcomes in RTR with posttransplantation BS versus RTR without BS from 2000 to 2023. After the exclusion process and propensity matching, both cohorts consisted of 153 patients.</div></div><div><h3>Results</h3><div>RTR-BS had a significantly lower incidence of overall cancer and transplant-related cancers (<em>P</em> &lt; .05). No significant difference was identified in cutaneous, gastrointestinal, and reproductive cancers. Percent Excess Weight Loss (%EWL) was significantly lower in RTR-only cohort (11.4%) versus RTR-BS cohort (57.8%) at 5 years. Sleeve gastrectomy (SG) patients (73.19%) had significantly higher %EWL than Roux en-Y gastric bypass (RYGB) patients (49.33%) at 3 years. No difference in cancer incidence was noted between SG and RYGB patients.</div></div><div><h3>Conclusion</h3><div>Postrenal transplantation BS had a diminishing effect on overall and transplant-related cancer incidence in RTR with severe obesity. Significant weight loss was also demonstrated with post-renal transplantation BS.</div></div>","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"20 12","pages":"Pages 1198-1205"},"PeriodicalIF":3.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141703811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anesthesia considerations for pediatric metabolic and bariatric surgery 小儿代谢和减肥手术的麻醉注意事项
IF 3.5 3区 医学 Q1 SURGERY Pub Date : 2024-12-01 DOI: 10.1016/j.soard.2024.07.004
Katherine Manupipatpong M.D. , Colton D. Wayne M.D. , Joseph D. Tobias M.D. , Olubukola O. Nafiu M.D., F.R.C.A., M.S. , Marc P. Michalsky M.D., M.B.A. , Ahsan Syed M.D.
Childhood obesity is a rapidly growing global health issue, linked to significant lifelong morbidity and mortality. Its impact on various organ systems increases perioperative complications. Obesity treatment in children and adolescents involves lifestyle, dietary, and behavioral modifications, as well as pharmacologic interventions that targets hormonal, metabolic, and neurochemical abnormalities. Metabolic and bariatric surgery, proven safe and effective for adults with severe obesity (class 2 or higher), is now being recommended for adolescents. Key anesthetic considerations for these surgeries include preoperative optimization, advanced airway management, targeted ventilation strategies, and opioid-sparing analgesic regimens. Comprehensive presurgical evaluations must address co-morbid conditions such as hypertension, obstructive sleep apnea, asthma, and impaired glycemic control. Preoperative management should also consider the effects of antiobesity medications on gastric emptying and hemodynamic stability. Ventilation strategies should prevent atelectasis while avoiding barotrauma, and drug dosages must be adjusted for altered pharmacokinetics due to increased adipose tissue. Employing enhanced recovery after surgery protocols may reduce perioperative complications, shorten postsurgical stays, and improve outcomes.
儿童肥胖是一个迅速增长的全球健康问题,与重大的终生发病率和死亡率有关。它对各种器官系统的影响增加了围手术期并发症。儿童和青少年的肥胖治疗包括生活方式、饮食和行为的改变,以及针对激素、代谢和神经化学异常的药物干预。代谢和减肥手术被证明对成人严重肥胖(2级或以上)安全有效,现在被推荐用于青少年。这些手术的关键麻醉考虑包括术前优化,先进的气道管理,有针对性的通气策略和阿片类镇痛方案。全面的术前评估必须针对合并症,如高血压、阻塞性睡眠呼吸暂停、哮喘和血糖控制受损。术前管理还应考虑抗肥胖药物对胃排空和血流动力学稳定性的影响。通气策略应在避免气压损伤的同时防止肺不张,并且必须根据脂肪组织增加引起的药代动力学改变调整药物剂量。采用增强术后恢复方案可以减少围手术期并发症,缩短术后停留时间,改善预后。
{"title":"Anesthesia considerations for pediatric metabolic and bariatric surgery","authors":"Katherine Manupipatpong M.D. ,&nbsp;Colton D. Wayne M.D. ,&nbsp;Joseph D. Tobias M.D. ,&nbsp;Olubukola O. Nafiu M.D., F.R.C.A., M.S. ,&nbsp;Marc P. Michalsky M.D., M.B.A. ,&nbsp;Ahsan Syed M.D.","doi":"10.1016/j.soard.2024.07.004","DOIUrl":"10.1016/j.soard.2024.07.004","url":null,"abstract":"<div><div>Childhood obesity is a rapidly growing global health issue, linked to significant lifelong morbidity and mortality. Its impact on various organ systems increases perioperative complications. Obesity treatment in children and adolescents involves lifestyle, dietary, and behavioral modifications, as well as pharmacologic interventions that targets hormonal, metabolic, and neurochemical abnormalities. Metabolic and bariatric surgery, proven safe and effective for adults with severe obesity (class 2 or higher), is now being recommended for adolescents. Key anesthetic considerations for these surgeries include preoperative optimization, advanced airway management, targeted ventilation strategies, and opioid-sparing analgesic regimens. Comprehensive presurgical evaluations must address co-morbid conditions such as hypertension, obstructive sleep apnea, asthma, and impaired glycemic control. Preoperative management should also consider the effects of antiobesity medications on gastric emptying and hemodynamic stability. Ventilation strategies should prevent atelectasis while avoiding barotrauma, and drug dosages must be adjusted for altered pharmacokinetics due to increased adipose tissue. Employing enhanced recovery after surgery protocols may reduce perioperative complications, shorten postsurgical stays, and improve outcomes.</div></div>","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"20 12","pages":"Pages 1322-1328"},"PeriodicalIF":3.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141710931","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retention and transition to adult health care in adolescent bariatric surgery 青少年减肥手术的保留和向成人医疗保健的过渡
IF 3.5 3区 医学 Q1 SURGERY Pub Date : 2024-12-01 DOI: 10.1016/j.soard.2024.06.005
Laura C. Hart M.D., M.P.H. , Ihuoma Eneli M.D., M.S.
The American Society of Metabolic and Bariatric Surgery (ASMBS) and the American Academy of Pediatrics (AAP) recommend bariatric surgery as a treatment option for severe obesity. Bariatric surgery results in weight loss and improves obesity-related comorbidities. After surgery, adolescents and young adults require close observation and interdisciplinary care to help optimize weight loss, minimize nutrient deficiencies, address mental or physical health complications, and ensure a smooth transition to adult care. Yet, the extant literature on adherence and transition of care in bariatric programs is limited. Using 3 case studies from 2 bariatric programs, one on retention and 2 on transition of care, this paper highlights learning opportunities for care delivery after bariatric surgery. A quality improvement framework and an embedded electronic medical health registry can improve retention rates within a bariatric program. In addition, implementing a workflow ensures standardization of care; however, a key challenge is inadequate staffing. The programs established a transition of care policy and protocol by incorporating several of the Six Core Elements, a recognized guide for ensuring a safe and appropriate transfer from pediatric to adult care. Several research gaps remain, and further work is needed to determine and standardize best practices for adolescent bariatric surgery.
美国代谢和减肥外科学会(ASMBS)和美国儿科学会(AAP)建议将减肥手术作为严重肥胖的治疗选择。减肥手术可以减轻体重并改善与肥胖相关的合并症。手术后,青少年和年轻人需要密切观察和跨学科护理,以帮助优化减肥效果,最大限度地减少营养缺乏,解决精神或身体健康并发症,并确保顺利过渡到成人护理。然而,现有的文献对坚持和过渡护理减肥计划是有限的。本文采用来自2个减肥项目的3个案例研究,1个关于保留,2个关于护理过渡,强调了减肥手术后护理交付的学习机会。质量改进框架和嵌入式电子医疗健康登记可以提高减肥计划的保留率。此外,实施工作流程可确保护理的标准化;然而,一个关键的挑战是人手不足。这些项目通过纳入六个核心要素中的几个,建立了一个护理政策和协议的过渡,这是一个公认的指南,确保从儿科到成人护理的安全和适当的转移。一些研究空白仍然存在,需要进一步的工作来确定和标准化青少年减肥手术的最佳实践。
{"title":"Retention and transition to adult health care in adolescent bariatric surgery","authors":"Laura C. Hart M.D., M.P.H. ,&nbsp;Ihuoma Eneli M.D., M.S.","doi":"10.1016/j.soard.2024.06.005","DOIUrl":"10.1016/j.soard.2024.06.005","url":null,"abstract":"<div><div>The American Society of Metabolic and Bariatric Surgery (ASMBS) and the American Academy of Pediatrics (AAP) recommend bariatric surgery as a treatment option for severe obesity. Bariatric surgery results in weight loss and improves obesity-related comorbidities. After surgery, adolescents and young adults require close observation and interdisciplinary care to help optimize weight loss, minimize nutrient deficiencies, address mental or physical health complications, and ensure a smooth transition to adult care. Yet, the extant literature on adherence and transition of care in bariatric programs is limited. Using 3 case studies from 2 bariatric programs, one on retention and 2 on transition of care, this paper highlights learning opportunities for care delivery after bariatric surgery. A quality improvement framework and an embedded electronic medical health registry can improve retention rates within a bariatric program. In addition, implementing a workflow ensures standardization of care; however, a key challenge is inadequate staffing. The programs established a transition of care policy and protocol by incorporating several of the Six Core Elements, a recognized guide for ensuring a safe and appropriate transfer from pediatric to adult care. Several research gaps remain, and further work is needed to determine and standardize best practices for adolescent bariatric surgery.</div></div>","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"20 12","pages":"Pages 1314-1321"},"PeriodicalIF":3.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141712562","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rare events model of the MBSAQIP database: risk of early bowel obstruction following metabolic surgery MBSAQIP 数据库的罕见事件模型:代谢手术后早期肠梗阻的风险
IF 3.5 3区 医学 Q1 SURGERY Pub Date : 2024-12-01 DOI: 10.1016/j.soard.2024.07.005
Teresa H. Schauer B.S. , Michael Kachmar D.O. , Florina Corpodean M.D. , Kathyrn P. Belmont B.S. , Denise Danos Ph.D. , Michael W. Cook M.D. , Philip R. Schauer M.D. , Vance L. Albaugh M.D., Ph.D.

Background

Early small bowel obstruction (eSBO) (within 30-days) is a rare but important complication that is associated with high rates of morbidity, including readmission, reintervention, and reoperation.

Objectives

To identify patient-specific and operation-specific characteristics that predispose patients to eSBO and to identify at-risk individuals preoperatively.

Setting

2015-2021 Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP).

Methods

Utilizing the 2015-2021 MBSAQIP PUF, 1,016,484 records were analyzed. Pediatric, revisional, open-conversion, and cases with incomplete data in sex, body mass index, operative-time, 30-day-follow-up variables were excluded. Case details were compared using Fisher’s exact & Wilcoxon -Mann -Whitney tests to identify at-risk patients. The likelihood of eSBO was modeled with rare event logistic regression.

Results

Incidence of eSBO was .40%. Of the 4103 occurrences of eSBO, RYGB (Roux-en-Y gastric bypass), SG (sleeve gastrectomy), and DS (duodenal switch) accounted for 79.4%, 19.3%, and 1.3%, respectively. Many patient-specific characteristics were significantly associated with eSBO. History of prior foregut surgery, a non-metabolic surgery trained operator, and longer operative times were all associated with increased eSBO (P < .0001). While simultaneously controlling for these factors, eSBO remained higher in DS (OR 9.55, P < .0001) and RYGB (OR 5.18, P < .0001) compared to SG. Increased length of operation (OR 1.03, P < .0001) and non -MS-trained operators (OR 1.33, P < .0001) remained highly significant. Male-sex (OR .70, P < .0001) and diabetes (OR .78, P < .0001) were both protective.

Conclusions

In the largest analysis to date, eSBO remains a rare event. RYGB accounts for the largest proportion of eSBO, however, DS has a higher risk adjusted rate of eSBO.
重度小肠梗阻(eSBO)(30天内)是一种罕见但重要的并发症,其发病率高,包括再入院、再干预和再手术。目的确定易患eSBO的患者特异性和手术特异性特征,并在术前识别高危个体。2015-2021年代谢和减肥手术认证和质量改进计划(MBSAQIP)。方法采用2015-2021年MBSAQIP PUF,对1016484份病历进行分析。排除儿童、修正、开放转换以及性别、体重指数、手术时间、30天随访变量数据不完整的病例。使用Fisher精确的&;Wilcoxon -Mann -Whitney测试来识别高危患者。eSBO的可能性用罕见事件逻辑回归建模。结果eSBO发生率为0.40%。在4103例eSBO中,RYGB (Roux-en-Y胃旁路术)、SG(套管胃切除术)和DS(十二指肠开关术)分别占79.4%、19.3%和1.3%。许多患者特异性特征与eSBO显著相关。前肠手术史、非代谢手术训练有素的操作者和较长的手术时间都与eSBO增加有关(P <;。)。在同时控制这些因素的情况下,DS患者的eSBO仍然较高(OR 9.55, P <;0.0001)和RYGB (OR 5.18, P <;0.0001)与SG相比。增加操作长度(OR 1.03, P <;0.0001)和未经ms培训的操作人员(OR 1.33, P <;0.0001)仍然非常显著。男性-性别(OR .70, P <;0.0001)和糖尿病(OR .78, P <;.0001)都是保护性的。在迄今为止最大规模的分析中,eSBO仍然是一个罕见的事件。RYGB的eSBO占比最大,DS的eSBO风险调整率更高。
{"title":"Rare events model of the MBSAQIP database: risk of early bowel obstruction following metabolic surgery","authors":"Teresa H. Schauer B.S. ,&nbsp;Michael Kachmar D.O. ,&nbsp;Florina Corpodean M.D. ,&nbsp;Kathyrn P. Belmont B.S. ,&nbsp;Denise Danos Ph.D. ,&nbsp;Michael W. Cook M.D. ,&nbsp;Philip R. Schauer M.D. ,&nbsp;Vance L. Albaugh M.D., Ph.D.","doi":"10.1016/j.soard.2024.07.005","DOIUrl":"10.1016/j.soard.2024.07.005","url":null,"abstract":"<div><h3>Background</h3><div>Early small bowel obstruction (eSBO) (within 30-days) is a rare but important complication that is associated with high rates of morbidity, including readmission, reintervention, and reoperation.</div></div><div><h3>Objectives</h3><div>To identify patient-specific and operation-specific characteristics that predispose patients to eSBO and to identify at-risk individuals preoperatively.</div></div><div><h3>Setting</h3><div>2015-2021 Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP).</div></div><div><h3>Methods</h3><div>Utilizing the 2015-2021 MBSAQIP PUF, 1,016,484 records were analyzed. Pediatric, revisional, open-conversion, and cases with incomplete data in sex, body mass index, operative-time, 30-day-follow-up variables were excluded. Case details were compared using Fisher’s exact &amp; Wilcoxon -Mann -Whitney tests to identify at-risk patients. The likelihood of eSBO was modeled with rare event logistic regression.</div></div><div><h3>Results</h3><div>Incidence of eSBO was .40%. Of the 4103 occurrences of eSBO, RYGB (Roux-en-Y gastric bypass), SG (sleeve gastrectomy), and DS (duodenal switch) accounted for 79.4%, 19.3%, and 1.3%, respectively. Many patient-specific characteristics were significantly associated with eSBO. History of prior foregut surgery, a non-metabolic surgery trained operator, and longer operative times were all associated with increased eSBO (<em>P</em> &lt; .0001). While simultaneously controlling for these factors, eSBO remained higher in DS (OR 9.55, <em>P</em> &lt; .0001) and RYGB (OR 5.18, <em>P</em> &lt; .0001) compared to SG. Increased length of operation (OR 1.03, <em>P</em> &lt; .0001) and non -MS-trained operators (OR 1.33, <em>P</em> &lt; .0001) remained highly significant. Male-sex (OR .70, <em>P</em> &lt; .0001) and diabetes (OR .78, <em>P</em> &lt; .0001) were both protective.</div></div><div><h3>Conclusions</h3><div>In the largest analysis to date, eSBO remains a rare event. RYGB accounts for the largest proportion of eSBO, however, DS has a higher risk adjusted rate of eSBO.</div></div>","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"20 12","pages":"Pages 1216-1224"},"PeriodicalIF":3.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141842743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
SOARD Category 1 CME Credit Featured Articles, Volume 20, December 2024 SOARD第一类CME信用专题文章,第20卷,2024年12月
IF 3.5 3区 医学 Q1 SURGERY Pub Date : 2024-12-01 DOI: 10.1016/j.soard.2024.10.027
{"title":"SOARD Category 1 CME Credit Featured Articles, Volume 20, December 2024","authors":"","doi":"10.1016/j.soard.2024.10.027","DOIUrl":"10.1016/j.soard.2024.10.027","url":null,"abstract":"","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"20 12","pages":"Pages 1402-1404"},"PeriodicalIF":3.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142743411","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment on: Cancer incidence following bariatric surgery in renal transplant recipients: a retrospective multicenter analysis 评论肾移植受者减肥手术后的癌症发病率:一项多中心回顾性分析。
IF 3.5 3区 医学 Q1 SURGERY Pub Date : 2024-12-01 DOI: 10.1016/j.soard.2024.07.016
Walter J. Pories M.D., F.A.C.S., Colonel M.C. U.S.A. (RET.)
{"title":"Comment on: Cancer incidence following bariatric surgery in renal transplant recipients: a retrospective multicenter analysis","authors":"Walter J. Pories M.D., F.A.C.S., Colonel M.C. U.S.A. (RET.)","doi":"10.1016/j.soard.2024.07.016","DOIUrl":"10.1016/j.soard.2024.07.016","url":null,"abstract":"","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"20 12","pages":"Page 1206"},"PeriodicalIF":3.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142127722","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment on: Rare events model of the MBSAQIP database: risk of early bowel obstruction following metabolic surgery 评论:MBSAQIP数据库的罕见事件模型:代谢手术后早期肠梗阻的风险。
IF 3.5 3区 医学 Q1 SURGERY Pub Date : 2024-12-01 DOI: 10.1016/j.soard.2024.08.015
Adisa Poljo M.D., Ralph Peterli M.D.
{"title":"Comment on: Rare events model of the MBSAQIP database: risk of early bowel obstruction following metabolic surgery","authors":"Adisa Poljo M.D.,&nbsp;Ralph Peterli M.D.","doi":"10.1016/j.soard.2024.08.015","DOIUrl":"10.1016/j.soard.2024.08.015","url":null,"abstract":"","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"20 12","pages":"Pages 1224-1225"},"PeriodicalIF":3.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142134973","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Iron homeostasis in obesity and metabolic and bariatric surgery: a narrative review 肥胖、代谢和减肥手术中的铁平衡:叙述性综述
IF 3.5 3区 医学 Q1 SURGERY Pub Date : 2024-12-01 DOI: 10.1016/j.soard.2024.08.018
Peter N. Benotti M.D. , Jila Kaberi-Otarod M.D. , G. Craig Wood M.S. , Glenn S. Gerhard M.D. , Christopher D. Still D.O. , Bruce R. Bistrian M.D., Ph.D.
Iron deficiency has been recognized as a potentially modifiable nutritional complication of metabolic and bariatric surgery (MBS) since prior to the turn of the century. Despite this, it remains the most common and clinically significant nutritional complication of this surgery with the potential to negate quality of life and the health benefits of surgical weight loss. This narrative review summarizes the current literature regarding iron deficiency as it relates to patients with severe obesity and those who undergo MBS. Advances in the clinical knowledge of iron homeostasis in severe obesity as a chronic disease, current diagnostic criteria for the diagnosis of iron deficiency in this patient population, the significance of preoperative iron deficiency, postoperative iron deficiency, and the status of supplementation and treatment will be reviewed with emphasis on gaps in knowledge and needed areas of further study.
早在本世纪初,人们就已经认识到铁缺乏症是代谢和减肥手术(MBS)的一种潜在营养并发症。尽管如此,铁缺乏症仍然是该手术最常见、最具临床意义的营养并发症,有可能影响生活质量和手术减肥的健康益处。这篇叙述性综述总结了目前有关铁缺乏症的文献,因为它与重度肥胖症患者和接受 MBS 的患者有关。将回顾重度肥胖作为一种慢性疾病的铁平衡临床知识的进展、当前诊断该患者群体缺铁的诊断标准、术前缺铁的意义、术后缺铁以及补充和治疗的现状,并重点关注知识差距和需要进一步研究的领域。
{"title":"Iron homeostasis in obesity and metabolic and bariatric surgery: a narrative review","authors":"Peter N. Benotti M.D. ,&nbsp;Jila Kaberi-Otarod M.D. ,&nbsp;G. Craig Wood M.S. ,&nbsp;Glenn S. Gerhard M.D. ,&nbsp;Christopher D. Still D.O. ,&nbsp;Bruce R. Bistrian M.D., Ph.D.","doi":"10.1016/j.soard.2024.08.018","DOIUrl":"10.1016/j.soard.2024.08.018","url":null,"abstract":"<div><div>Iron deficiency has been recognized as a potentially modifiable nutritional complication of metabolic and bariatric surgery (MBS) since prior to the turn of the century. Despite this, it remains the most common and clinically significant nutritional complication of this surgery with the potential to negate quality of life and the health benefits of surgical weight loss. This narrative review summarizes the current literature regarding iron deficiency as it relates to patients with severe obesity and those who undergo MBS. Advances in the clinical knowledge of iron homeostasis in severe obesity as a chronic disease, current diagnostic criteria for the diagnosis of iron deficiency in this patient population, the significance of preoperative iron deficiency, postoperative iron deficiency, and the status of supplementation and treatment will be reviewed with emphasis on gaps in knowledge and needed areas of further study.</div></div>","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"20 12","pages":"Pages 1370-1380"},"PeriodicalIF":3.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142219340","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Surgery for Obesity and Related Diseases
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1